FDA recall record

Philips HeartStart MRx Monitor/Defibrillator Model # M3535A - Product Usage: The HeartStart recall — FDA Z-2488-2019

Non-conforming devices are identified, which may not have been included in prior field actions and may not have had a number of corrections applicable to…

Class IIclassification
Z-2488-2019official record ID
Sep 18, 2019report date

Recall record at a glance

Official recordZ-2488-2019
CategoryMedical Device Recalls
ClassificationClass II
FDA record statusTerminated
Recalling firmPhilips North America, LLC
Report dateSep 18, 2019
Recall initiation dateJul 16, 2019
Quantity2 units
LocationAndover, MA, United States

Official product description

HeartStart MRx Monitor/Defibrillator Model # M3535A - Product Usage: The HeartStart MRx is a lightweight, portable external defibrillator, offering two modes of operation for defibrillation: manual mode and semi-automatic mode (AED). In manual mode, the HeartStart MRx is a full featured manual defibrillator, designed for use by clinicians trained in Advanced Cardiac Life Support (ACLS). Manual operation allows users to select energy levels for external and internal defibrillation. Users may also perform synchronized cardioversion. Non-invasive external pacing is a device option. In AED mode, the HeartStart MRx allows the provider who is trained in Basic Life Support (BLS) to provide defibrillation therapy. The device analyzes a patient s rhythm and advises the user to deliver a shock. Voice prompts guide the user through the defibrillation process by providing instructions and patient information. The voice prompts are reinforced by messages that appear on the display. In both modes of operation, the HeartStart MRx utilizes impedance compensating biphasic truncated exponential therapy waveform. The HeartStart MRx can also be used for ECG monitoring of a patient using 3, 5 or 12 lead cables.

Why the product was recalled

Non-conforming devices are identified, which may not have been included in prior field actions and may not have had a number of corrections applicable to these devices.

Distribution information

US Nationwide distribution in the state of MA.

How to read the classification

FDA Class II indicates a situation in which use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote. The classification shown here comes from the FDA record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.

Related recall records

Other records from the same recalling company are shown first when available.

Medical DeviceSep 9, 2026

Philips Brilliance recall — FDA Z-3040-2026

Philips has identified an unintended radiation issue with the Philips IQon, iCT, Ingenuity, and Brilliance CT 64 systems that could affect the performance of the equipment.

Class IIFDA: OngoingPhilips North America LLC